GASTRIC CANCER ADENOCARCINOMA METASTATIC
Clinical trials for GASTRIC CANCER ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for GASTRIC CANCER ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo offers hope for stomach cancer patients who failed immunotherapy
Disease control Recruiting nowThis study tests a new combination of drugs (fruquintinib, nab-paclitaxel, and a bispecific antibody) as a second treatment for people with advanced stomach cancer that got worse after immunotherapy. About 68 adults will take part. The goal is to see if this combo can shrink tumo…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Dai, Guanghai • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New hope for stomach cancer: first human trial of BDC-4182 begins
Disease control Recruiting nowThis study tests a new drug called BDC-4182 in people with advanced stomach or gastroesophageal cancer that has spread or cannot be removed by surgery. The goal is to see if the drug is safe and shrinks tumors. About 122 participants will receive the drug alone, and researchers w…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for stomach cancer patients with fluid buildup: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of three drugs (lenvatinib, nivolumab, and chemotherapy) in people with advanced stomach cancer that has spread and caused fluid buildup in the belly. The goal is to see if this treatment can shrink tumors and help patients live longer without the c…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New hope for stomach cancer: targeted drug combo shows promise
Disease control Recruiting nowThis study tests whether adding the drug Zolbetuximab to standard chemotherapy can help people with a specific type of advanced stomach or esophageal cancer live longer. It is for patients whose tumors have a certain protein (CLDN18.2) and who have already had one prior treatment…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated May 07, 2026 18:39 UTC